Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide
暂无分享,去创建一个
Lara A Kahale | Gordon H Guyatt | Thomas Agoritsas | Jason W Busse | Elie A Akl | Romina Brignardello-Petersen | Pablo Alonso-Coello | Ignacio Neumann | Shanil Ebrahim | Bradley C Johnston | Lara A. Kahale | G. Guyatt | E. Akl | B. Johnston | T. Agoritsas | P. Alonso-Coello | J. Busse | I. Neumann | R. Brignardello-Petersen | A. Carrasco-Labra | S. Ebrahim | I. Solá | P. Vandvik | Yuqing Zhang | Xin Sun | Xin Sun | Yuqing Zhang | Ivan Sola | Per Vandvik | Khaled Shawwa | Alonso Carrasco–Labra | K. Shawwa
[1] G. Piaggio,et al. Consort 2010 statement: extension to cluster randomised trials , 2012, BMJ : British Medical Journal.
[2] R. Little,et al. The design and conduct of clinical trials to limit missing data , 2012, Statistics in medicine.
[3] Thomas Agoritsas,et al. Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches , 2015, Systematic Reviews.
[4] M. Kenward,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.
[5] Gordon H Guyatt,et al. Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers. , 2014, Journal of clinical epidemiology.
[6] J. Ioannidis,et al. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.
[7] D. Patrick. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] D. Polit,et al. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy. , 2010, Research in nursing & health.
[9] J. Harman,et al. Attrition and related trends in scientific rigor: A score card for ART adherence intervention research and recommendations for future directions , 2008, Current HIV/AIDS reports.
[10] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[11] G. Antes,et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials , 2011 .
[12] J Zhang,et al. Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study , 2006, Pharmaceutical statistics.
[13] D. Osoba,et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. , 1998, Statistics in medicine.
[14] David Moher,et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.
[15] Yvonne Sylvestre. CONSORT: missing missing data guidelines, the effects on HTA monograph reporting , 2011, Trials.
[16] Matthias Briel,et al. Inconsistent Definitions for Intention-To-Treat in Relation to Missing Outcome Data: Systematic Review of the Methods Literature , 2012, PloS one.
[17] D. Osoba,et al. Guidelines for reporting results of quality of life assessments in clinical trials , 1996, Quality of Life Research.
[18] David Moher,et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. , 2013, JAMA.
[19] N. Black. CONSORT , 1996, The Lancet.
[20] R T O'Neill,et al. The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It , 2012, Clinical pharmacology and therapeutics.
[21] Matthias Briel,et al. Addressing Dichotomous Data for Participants Excluded from Trial Analysis: A Guide for Systematic Reviewers , 2013, PloS one.
[22] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[23] J. Farrar,et al. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations , 2014, PAIN®.
[24] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[25] V. Montori,et al. An efficient strategy allowed English-speaking reviewers to identify foreign-language articles eligible for a systematic review. , 2014, Journal of clinical epidemiology.
[26] Xin Sun,et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. , 2013, Journal of clinical epidemiology.
[27] Gordon H Guyatt,et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review , 2012, BMJ : British Medical Journal.
[28] A. Troxel,et al. Statistical analysis of quality of life with missing data in cancer clinical trials. , 1998, Statistics in medicine.